predictive-modeling
(7)
The Marketing Agency That Knows Your Mailbox Is Still a Media Channel
Amsive connects consumer data, search, media, creative, and industrial-scale mail into one performance system. The proposition is practical: find the next best customer, reach them in more than one place, and prove what happened afterward.
Pecan AI
Pecan AI is an Israeli-American software company that builds a predictive analytics platform aimed at business teams rather than data scientists. Founded in 2018 by computational-neuroscience PhDs Zohar Bronfman and Noam Brezis, Pecan combines automated machine learning with large language models - a category it calls Predictive GenAI - so analysts can describe a business problem in plain language and get production-ready predictive models for churn, customer lifetime value, demand forecasting, lead scoring and campaign ROI. The company has raised roughly $127M, including a $66M Series C in 2022 led by Insight Partners with GV and GGV Capital, and in 2025 launched DemandForecast.ai for supply-chain forecasting.
Arbital Health
Arbital Health is a San Francisco-based healthcare technology company that combines an AI-powered software platform with a bench of credentialed actuaries to help payers and providers design, monitor, reconcile, and adjudicate value-based and risk-based contracts. Founded in November 2023 by Travis May and Brian Overstreet, it positions itself as a neutral third-party infrastructure layer for the shift to value-based care, centralizing fragmented claims, benchmark, and contract data and automating actuarial calculations such as IBNR and MLR.
NobleAI
NobleAI is a San Francisco software company that builds 'Science-Based AI' for chemical, materials and energy R&D. Its cloud VIP platform (Visualizations, Insights and Predictions) bakes physical laws and chemical properties into machine-learning models so they can make useful predictions from the sparse, messy datasets that industrial labs actually have - compressing R&D cycles from months to minutes. Founded in 2017 by physicist Matthew C. Levy, the company has raised roughly $40M from backers including Microsoft's M12, Chevron Technology Ventures, Sway Ventures and Dorilton, and counts chemical giants such as Solvay among its early partners.
Accorded
Accorded is a San Francisco-based healthcare actuarial intelligence company that pairs actuarial expertise with software to simplify and scale value-based contracting. Its platform helps payers, providers, and digital-health companies forecast, contract around, and validate the financial value of care across the value-based contracting lifecycle. Founded in 2019 (originally as Cerebrae) by health actuary Frank Cheung and engineer Thomas Bedington, the company's flagship product, Acumen, turns raw claims, eligibility, and engagement data into standardized, actuarially rigorous, ready-to-use data assets so analytics teams can spend less time wrangling data and more time on strategy.
Inductive Bio
Inductive Bio is a New York-based AI company building a machine learning platform that predicts how small-molecule drugs will behave in the body before they are ever synthesized. By training models on a pre-competitive data consortium shared across biopharma teams, its Beacon models, Compass software, and Indy chemistry assistant help medicinal chemists nominate better development candidates faster - reducing the costly 'whack-a-mole' of balancing potency against ADMET properties in preclinical drug discovery.
Windfall
Windfall is a San Francisco-based people intelligence and AI company that estimates the net worth, career signals, and giving capacity of every U.S. household, then plugs that data into the workflows that go-to-market and fundraising teams already use. Founded in 2016 by Arup Banerjee, Cory Tucker, and Dan Stevens, it serves more than 1,500 organizations - from Make-A-Wish to the University of Michigan - and raised a $65M Series B from Morgan Stanley Expansion Capital in 2025.